← Back to Clinical Trials
Recruiting Phase 4 NCT07169760

R61/33 - VR Study Phase 4

Trial Parameters

Condition Attention Deficit Hyperactivity Disorder
Sponsor Rutgers, The State University of New Jersey
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 252
Sex ALL
Min Age 18 Years
Max Age 25 Years
Start Date 2025-09-09
Completion 2030-09
Interventions
Meta Quest 3 VR Headset with noise cancelling headphones

Brief Summary

The goal of this larger parallel group randomized trial is to test the impact of a virtual reality program for improving the ability of emerging adults (age 18-25) with attention deficit hyperactivity disorder (ADHD) to stay focused while completing homework and studying. This study compares the impact of using a virtual reality headset to using a virtual reality headset while also receiving feedback about levels of focus to a control group. The main question is whether participants demonstrate significantly improved concentration while completing homework and studying in virtual reality and whether they enjoy and prefer working in a virtual reality environment. Concentration is measured both through participant report and also using keyboard and mouse click data to assess work productivity objectively.

Eligibility Criteria

Inclusion Criteria: * Participants must meet DSM-5 criteria for ADHD * Between the ages of 18 and 25 * Given high rates of comorbidities in college students with ADHD, participants who meet criteria for ODD, anxiety or depressive disorders on the diagnostic interview are not excluded * Participants must have an item mean score of \>2.0 (often or very often) on the homework task specific version of the Adult Concentration Index (ACI), ensuring the presence of a problem in the mechanism being targeted in this study * The participant has to endorse a total of at least 5 symptoms in the ADHD inattention domain as currently present and impairing and at least 6 symptoms in the ADHD inattention domain as present and impairing during childhood * To rule out exclusionary conditions and/or to assess for the presence of comorbid conditions, psychological functioning will be assessed using the DSM-5 version of the Structured Clinical Interview for DSM Disorders (SCID-5-RV) Exclusion Criteria: * Wh

Related Trials